$0.0473
0.000280.60%
At close: -
Comments
Loading...
Nanopharmaceutics Analyst Ratings and Price Targets | OTC:TGRP | Benzinga
Nanopharmaceutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Nanopharmaceutics Corp from these most-recent analyst ratings.
Analyst Ratings for Nanopharmaceutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Nanopharmaceutics (TGRP) stock?
There is no price target for Nanopharmaceutics
What is the most recent analyst rating for Nanopharmaceutics (TGRP)?
There is no analyst for Nanopharmaceutics
When was the last upgrade for Nanopharmaceutics (TGRP)?
There is no last upgrade for Nanopharmaceutics
When was the last downgrade for Nanopharmaceutics (TGRP)?
There is no last downgrade for Nanopharmaceutics.
When is the next analyst rating going to be posted or updated for Nanopharmaceutics (TGRP)?
There is no next analyst rating for Nanopharmaceutics.
Is the Analyst Rating Nanopharmaceutics (TGRP) correct?
There is no next analyst rating for Nanopharmaceutics.
Browse analyst ratings and price targets on all stocks.